Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Precision Dosing of Metformin in Youth With Type 2 Diabetes
NCT06120881Phase 1Recruiting
- Sponsor
- University of California, San Francisco
- Start
- Apr 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by University of California, San Francisco. Primary endpoints: Acceptability of Intervention Measure at 3 months and Feasibility of Intervention Measure at 3 months. Started Apr 2024; status: recruiting.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT06120881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06120881.